Willy E Peetermans Selected Research

Therapeutics

5/2022	Clinical Efficacy and Safety of Vancomycin Continuous Infusion in Patients Treated at Home in an Outpatient Parenteral Antimicrobial Therapy Program.
1/2021	Bacteriophage Therapy for Difficult-to-Treat Infections: The Implementation of a Multidisciplinary Phage Task Force (The PHAGEFORCE Study Protocol).
1/2021	Impact of Check of Medication Appropriateness (CMA) in optimizing analgesic prescribing: An interrupted time series analysis.
8/2017	Incidence and risk factors of fever in a contemporary cohort of HIV-patients with good access to antiretroviral therapy.
1/2017	Clinical presentation, causes and outcome of febrile episodes in a prospective cohort of HIV-infected patients.
11/2016	Comparison of PCR-Electrospray Ionization Mass Spectrometry with 16S rRNA PCR and Amplicon Sequencing for Detection of Bacteria in Excised Heart Valves.
3/2013	Length of stay after reaching clinical stability drives hospital costs associated with adult community-acquired pneumonia.
12/2011	Empirical management of community-acquired pneumonia: impact of concurrent A/H1N1 influenza pandemic on guideline implementation.
9/2011	Anti-thrombotic therapy in infective endocarditis.
6/2010	(18)F-FDG PET/CT for early detection of embolism and metastatic infection in patients with infective endocarditis.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Willy E Peetermans Research Topics

Disease

15	Infections 05/2022 - 02/2004
9	Pneumococcal Infections 02/2023 - 08/2006
6	Sepsis (Septicemia) 01/2012 - 11/2002
5	Fever (Fevers) 08/2017 - 06/2004
5	Endocarditis 11/2016 - 05/2008
4	Pneumonia (Pneumonitis) 09/2015 - 12/2011
3	Urinary Tract Infections (Urinary Tract Infection) 10/2022 - 06/2011
3	Hypersensitivity (Allergy) 10/2022 - 04/2016
3	Hemorrhage 04/2022 - 09/2007
3	Drug-Related Side Effects and Adverse Reactions 04/2022 - 01/2021
2	Critical Illness (Critically Ill) 10/2022 - 01/2012
2	Neoplasms (Cancer) 01/2022 - 05/2014
2	Inflammation (Inflammations) 10/2019 - 07/2009
2	Respiratory Tract Infections (Respiratory Tract Infection) 06/2011 - 02/2008
2	Catheter-Related Infections 06/2004 - 11/2002
1	Opioid-Induced Constipation 04/2022
1	Torsades de Pointes (Torsade de Pointes) 04/2022
1	Bacterial Infections (Bacterial Infection) 01/2022
1	Breakthrough Infections 01/2022
1	Chronic Renal Insufficiency 01/2022
1	Febrile Neutropenia 01/2022
1	Aspergillosis 09/2021
1	Stroke (Strokes) 01/2021
1	Heart Failure 01/2021
1	Diabetes Mellitus 01/2021
1	Persistent Infection 01/2021
1	Pain (Aches) 01/2021
1	Pyelonephritis 12/2020
1	Flushing 11/2020
1	Gastroenteritis 01/2019
1	Typhoid Fever (Typhoid) 09/2017
1	Acquired Immunodeficiency Syndrome (AIDS) 08/2017
1	Abdominal Pain (Pain, Abdominal) 04/2016
1	Irritable Bowel Syndrome (Syndrome, Irritable Bowel) 04/2016
1	Alcoholism (Alcohol Abuse) 11/2013
1	Staphylococcal Infections 07/2013
1	Hematologic Neoplasms (Hematological Malignancy) 01/2012
1	Necrosis 01/2012
1	Endophthalmitis (Ophthalmia) 10/2009
1	Embolism (Embolus) 12/2008
1	Septic Shock (Toxic Shock Syndrome) 04/2008
1	Abscess 11/2007
1	Bacteremia 10/2007
1	Cryoglobulinemia 03/2007

Drug/Important Bio-Agent (IBA)

10	Anti-Bacterial Agents (Antibiotics)IBA 01/2022 - 02/2004
4	Conjugate VaccinesIBA 02/2023 - 03/2013
3	VaccinesIBA 08/2021 - 06/2015
3	C-Reactive ProteinIBA 09/2017 - 06/2004
2	temocillinIBA 10/2022 - 06/2020
2	beta-LactamsIBA 10/2022 - 01/2007
2	Cefepime (Maxipime)FDA LinkGeneric 01/2022 - 11/2020
2	10-valent pneumococcal conjugate vaccineIBA 01/2022 - 01/2021
2	Voriconazole (Vfend)FDA LinkGeneric 09/2021 - 10/2009
2	Ciprofloxacin (Cipro)FDA LinkGeneric 09/2017 - 01/2012
2	FluoroquinolonesIBA 06/2011 - 01/2007
1	Pneumococcal Vaccines (Pneumococcal Polysaccharide Vaccine)IBA 02/2023
1	Vancomycin FDA LinkGeneric 05/2022
1	KetorolacIBA 04/2022
1	AnticoagulantsIBA 01/2022
1	Analgesics (Analgesic Drugs)IBA 01/2021
1	AminoglycosidesIBA 12/2020
1	Immunoglobulin E (IgE)IBA 01/2019
1	fibrin fragment D (D-dimer)IBA 01/2018
1	16S Ribosomal RNAIBA 11/2016
1	Histamine Receptors (Histamine Receptor)IBA 04/2016
1	von Willebrand FactorIBA 04/2016
1	CoagulaseIBA 04/2016
1	ebastine (Kestin)IBA 04/2016
1	Histamine (Histamine Dihydrochloride)FDA Link 04/2016
1	Polysaccharides (Glycans)IBA 06/2015
1	Glucose (Dextrose)FDA LinkGeneric 05/2014
1	FibrinIBA 07/2013
1	staphylothrombinIBA 07/2013
1	Dabigatran FDA Link 07/2013
1	Antilymphocyte Serum (Anti-Thymocyte Globulin)IBA 01/2012
1	Calcineurin InhibitorsIBA 01/2012
1	Azithromycin (Zithromax)FDA LinkGeneric 01/2012
1	Caspofungin (Cancidas)FDA Link 10/2009
1	Ferritins (Ferritin)IBA 07/2009
1	Trace Elements (Biometals)IBA 07/2009
1	4-cresol (p-cresol)IBA 07/2009
1	Uremic ToxinsIBA 07/2009
1	IronIBA 07/2009
1	cefuroxime axetil (Ceftin)FDA LinkGeneric 02/2008
1	Cefuroxime (Zinacef)FDA LinkGeneric 02/2008
1	P-2 (P 2)IBA 11/2007
1	Rituximab (Mabthera)FDA Link 03/2007

Therapy/Procedure

16	Therapeutics 05/2022 - 02/2004
8	Catheters 10/2019 - 11/2002
3	Inappropriate Prescribing 04/2022 - 01/2021
2	Phage Therapy 01/2022 - 01/2021
2	Renal Dialysis (Hemodialysis) 01/2021 - 07/2009
2	Central Venous Catheters 11/2020 - 06/2004
2	Length of Stay 03/2013 - 01/2012
1	Oral Hygiene (Dental Hygiene) 11/2013
1	Transplantation 01/2012
1	Resuscitation Orders (Do Not Resuscitate Orders) 01/2012
1	Conservative Treatment 04/2008
1	Prostheses and Implants (Prosthesis) 10/2007
1	Plasmapheresis 03/2007